BRKR
Bruker Corporation
NASDAQ: BRKR · HEALTHCARE · MEDICAL DEVICES
$34.29
-5.43% today
Updated 2026-04-29
Market cap
$5.52B
P/E ratio
—
P/S ratio
1.61x
EPS (TTM)
$-0.15
Dividend yield
0.55%
52W range
$28 – $56
Volume
2.0M
Bruker Corporation (BRKR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$34.29
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$59.07
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $3.0B | $3.4B | $3.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -0.25%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.